Convira Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Kanpur, Uttar Pradesh, India, established in 2012.
2012 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Convira Pharmaceuticals Private Limited

Convira Pharmaceuticals Private Limited, a active private limited company, was established on 30 January 2012 in Kanpur, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74120UP2012PTC048613. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.11 M.

It upholds a compliant status. Its leadership includes Payal Sahu (Director), Sujeet Sahu (Managing Director), Rajesh Sahu (Director). Past directors included Brijesh Agnihotri, Sujeet Sahu. It holds ₹0.95 M open charges and ₹2.00 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Raman Villa Apartment, Flat No. 102, 160-E Block, Shyam Nagar,, Kanpur, Uttar Pradesh, 208013.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74120UP2012PTC048613

  • Registration Number

    048613

  • Incorporation Date

    30 January 2012

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.11 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.11 M
  • Company Age 14 Year, 11 Days
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.95 M
  • Satisfied Charges ₹ 2.00 M
  • Revenue Growth **** -18.75%
  • Profit Growth **** -56.41%
  • Ebitda **** 16.64%
  • Net Worth -1.79%
  • Total Assets **** 2.53%
Company report

Convira Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Convira Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Convira Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Payal Sahu Director 30 Jan 2012 Current
Sujeet Sahu Managing Director 30 Jan 2012 Current
Rajesh Sahu Director 01 Apr 2025 Current
Brijesh Kumar Sahu Director 01 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 16 Jun 2014 Past
Pramod Abcsdd Director 31 Jan 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Convira Pharmaceuticals.

Convira Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.75% decrease. The company also saw a substantial fall in profitability, with a 56.41% decrease in profit. The company's net worth dipped by a decrease of 1.79%.

Convira Pharmaceuticals revenue growth over time
Convira Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -18.75%
*******
*******
*******
*******
Revenue from Operations
*******
 -18.75%
*******
*******
*******
*******
Total Assets
*******
 2.53%
*******
*******
*******
*******
Profit or Loss
*******
 -56.41%
*******
*******
*******
*******
Net Worth
*******
 -1.79%
*******
*******
*******
*******
EBITDA
*******
 16.64%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Convira Pharmaceuticals?

Unlock access to Convira Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹950,000.00

Satisfied Charges

₹2,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
27 Sep 2021 Others ₹0.95 M Open
27 Jul 2013 Bank Of India ₹2.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Convira Pharmaceuticals?

Unlock and access historical data on people associated with Convira Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Convira Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Convira Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Convira Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Convira Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Director Appointment

    The activity Rajesh Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 10 months 10 days . was completed.

  • Director Appointment

    Progress on Brijesh Kumar Sahu was appointed as a Director was appointed as a Director on 01 Apr 2025 & has been associated with this company since 10 months 10 days . was documented.

  • Balance Sheet

    Progress on Convira Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was documented.

  • Charges

    Progress on A charge with Others amounted to Rs. 0.95 M with Charge ID 100490687 was registered on 27 Sep 2021. was documented.

  • Charges

    Progress on A charge registered on 27 Jul 2013 via Charge ID 10443619 with Bank Of India was fully satisfied on 22 May 2019. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Convira Pharmaceuticals Private Limited?

The CIN of Convira Pharmaceuticals Private Limited is U74120UP2012PTC048613.

Where is Convira Pharmaceuticals Private Limited headquartered?

Convira Pharmaceuticals Private Limited is headquartered at Raman Villa Apartment, Flat No. 102, 160-E Block, Shyam Nagar,, Kanpur, Uttar Pradesh, 208013.

When was Convira Pharmaceuticals Private Limited incorporated?

Convira Pharmaceuticals Private Limited was incorporated on 30 January 2012.

Who are the current directors of Convira Pharmaceuticals Private Limited?

The current directors of Convira Pharmaceuticals Private Limited are

What is the primary industry of Convira Pharmaceuticals Private Limited?

The primary industry of Convira Pharmaceuticals Private Limited is Trade.

Is Convira Pharmaceuticals Private Limited a listed company?

Convira Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Convira Pharmaceuticals Private Limited?

The authorized capital of Convira Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.11 M.

What is the compliance status of Convira Pharmaceuticals Private Limited?

The compliance status of Convira Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available